Cargando…
Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin
We reported a patient with systemic lupus erythematosus complicated by livedoid vasculopathy (LV), who responded well to intravenous immunoglobulin and warfarin. Cutaneous lesions of LV resemble those of cutaneous vasculitis. LV should be included in the differential diagnosis of leg ulcerations eve...
Autores principales: | Yoshioka, Katsunobu, Tateishi, Chiharu, Kato, Hiromi, Chen, Ko‐Ron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230605/ https://www.ncbi.nlm.nih.gov/pubmed/30455888 http://dx.doi.org/10.1002/ccr3.1803 |
Ejemplares similares
-
Efficacy and safety of intravenous immunoglobulin for treating
refractory livedoid vasculopathy: a systematic review
por: Gao, Yimeng, et al.
Publicado: (2022) -
Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib
por: Jia, Ertao, et al.
Publicado: (2020) -
Adalimumab in Treating Refractory Livedoid Vasculopathy
por: Huang, Xiao-Wen, et al.
Publicado: (2022) -
Ulcerative livedoid vasculopathy responding to clopidogrel
por: Kunzler, Elaine, et al.
Publicado: (2018) -
Use of Low-dose Oral Warfarin in Three Cases of Livedoid Vasculopathy
por: Saoji, Vikrant, et al.
Publicado: (2017)